# Study Evaluating Denosumab on Vascular and Bone Metabolism in Osteoporotic Chronic Kidney Disease (HDENOBS)

> **NCT05234047** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 21 (estimated)

## Conditions studied

- Osteoporosis
- Chronic Kidney Disease 5D

## Interventions

- **PROCEDURE:** MDCT (multidetector computed tomography)
- **PROCEDURE:** Dual-energy X-ray absorptiometry

## Key facts

- **NCT ID:** NCT05234047
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05234047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05234047, "Study Evaluating Denosumab on Vascular and Bone Metabolism in Osteoporotic Chronic Kidney Disease (HDENOBS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05234047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*